BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 11213538)

  • 1. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of hypertension in obesity.
    Dornfeld LP; Maxwell MH; Waks A; Tuck M
    Kidney Int Suppl; 1987 Oct; 22():S254-8. PubMed ID: 3323617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symposium on the etiology of hypertension--summarizing studies in 20th century. 4. Pathogenesis of hypertension--kidney as a pathogenetic organ of hypertension.
    Hayashi K
    Intern Med; 2001 Feb; 40(2):153-6. PubMed ID: 11300152
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of sodium sensitivity to insulin resistance.
    Rocchini AP
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S75-80. PubMed ID: 8141170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and blood pressure regulation.
    Gans RO; Donker AJ
    J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?
    Sarafidis PA; Bakris GL
    Am J Nephrol; 2007; 27(1):44-54. PubMed ID: 17245074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats.
    Guo Q; Mori T; Jiang Y; Hu C; Osaki Y; Yoneki Y; Sun Y; Hosoya T; Kawamata A; Ogawa S; Nakayama M; Miyata T; Ito S
    J Hypertens; 2009 Aug; 27(8):1664-71. PubMed ID: 19531965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing evidence for the role of salt and salt-sensitivity in hypertension.
    Siani A; Guglielmucci F; Farinaro E; Strazzullo P
    Nutr Metab Cardiovasc Dis; 2000 Apr; 10(2):93-100. PubMed ID: 10919174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species and the central nervous system in salt-sensitive hypertension: possible relationship with obesity-induced hypertension.
    Ando K; Fujita M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):111-6. PubMed ID: 21388436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of salt retention to central activation of the sympathetic nervous system in hypertension.
    Brooks VL; Haywood JR; Johnson AK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):426-32. PubMed ID: 15854153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacological modulation of the renin-angiotensin-aldosterone system on salt sensitivity in patients with borderline hypertension.
    Borghi C; Boschi S; Costa FV; Bacchelli S; Degli Esposti D; Piccoli M; Ambrosioni E
    J Hypertens Suppl; 1993 Dec; 11(5):S248-9. PubMed ID: 8158368
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin and hypertension: are they related?
    Meehan WP; Darwin CH; Maalouf NB; Buchanan TA; Saad MF
    Przegl Lek; 1994; 51(3):135-48. PubMed ID: 8058982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
    de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
    Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of insulin resistance in arterial hypertension.
    Sechi LA; Bartoli E
    Blood Press Suppl; 1996; 1():47-54. PubMed ID: 9162438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
    Landsberg L
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S1-8. PubMed ID: 7519690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.